← Back
Data updated: Mar 10, 2026
CRYSTAL
CardiovascularInfectious DiseaseOncology
CRYSTAL is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Oncology.
2024
Since
1
Drugs
-
Trials
14
Approved (2yr)
Recent Activity
SACUBITRIL AND VALSARTAN 2026-01-20
SACUBITRIL AND VALSARTAN 2025-07-17
SACUBITRIL AND VALSARTAN 2025-07-16
SACUBITRIL AND VALSARTAN 2025-07-16
SACUBITRIL AND VALSARTAN 2025-01-13
SACUBITRIL AND VALSARTAN 2025-01-08
SACUBITRIL AND VALSARTAN 2024-10-16
SACUBITRIL AND VALSARTAN 2024-09-16
SACUBITRIL AND VALSARTAN 2024-08-30
SACUBITRIL AND VALSARTAN 2024-08-22
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 55%
1 drugs
Infectious Disease 27%
0 drugs Phase 2: 1 Phase 1: 1
Oncology 18%
0 drugs Phase 2: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular
Baxter specialty
Infectious Disease, Cardiovascular, Oncology
Johnson & Johnson big-pharma
Oncology, Infectious Disease, Cardiovascular
COSETTE other
Cardiovascular, Infectious Disease, Oncology
GE HEALTHCARE specialty
Infectious Disease, Cardiovascular, Oncology
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2024-05-28
- Latest
- 2024-05-28
- Applications
- 1